Sciformix Announces Expansion into Europe with New Office in UK

Sciformix Corporation has opened a new office in Manchester, UK expanding its global presence and footprint to include the European region. For more than 7 years, Sciformix has been supporting life science organizations with high quality services in the areas of safety and risk management, regulatory affairs and operations and clinical research and post-approval support. The opening of the new European office demonstrates Sciformix’s scalability and preparedness to combine optimized on-shore/off-shore models that enhance client value and experience while maximizing cost benefits.

By opening an office in the UK, Sciformix will seek to better service its existing global and European clients with near-shore presence and also build new relationships with potential clients across EMEA to further grow and diversify its client and revenue base. Sciformix’s unique combination of expert talent, LEAN processes, technology innovation and flexible operations provides an attractive option to life science organizations, small and large, who are seeking to establish strategic outsourcing partnerships.

With this expansion into Europe to complement its already established presence in the US and Asia with over 750 employees, Sciformix will be within arms reach of clients’ operations across three continents. With delivery functions operating also out of the European Union (EU), clients will experience Sciformix even more as an extension of their own operations.

For years, industry groups have lobbied the UK government to help establish and nurture a life sciences hub, similar to that in Boston, US where world-class research institutions abut promising biotech start-ups and Big Pharma. The UK is now striving to brand itself as a hotbed for biotech R&D, promising new funds for start-ups, pledging to speed up its approval process and courting some major players to deepen their roots in the country. Sciformix will be able to take advantage of this and play a key role in this growth.

Manish Soman, President & CEO, Sciformix Corporation commented: “Sciformix’s long-term strategy focuses on evolving and enhancing our service and technology offerings, broadening our global reach and growing and diversifying the client and revenue base. Building a European hub will support all of these objectives. With our clients’ growth in emerging markets, it has become increasingly important for us to truly understand the local safety and regulatory challenges our clients face and to become the partner of choice when it comes to outsourcing these activities. Sciformix is such a trusted provider.”

The new office will support all service lines, however, the initial focus will be on Consulting, Safety and Risk Management, Regulatory, and Labelling services.